Introduction
Atherosclerotic vascular diseases (AVD) are a major cause of morbidity and mortality. Combined hyperlipidemia (CH) is one of the usual features of metabolic syndrome, together with visceral obesity, impaired glucose tolerance and hypertension, which are increasingly prevalent factors for premature heart disease and make its treatment troublesome. [1] [2] [3] Combinations of therapeutic modalities from different classes of agents can be effective, well tolerated and safe in most hard-to-treat patients. 4 Atorvastatin and fenofibrate combination has a highly beneficial effect on all lipid parameters and plasma fibrinogen. It improved patients AVD risk status significantly more in comparison to each drug alone. 5 Atorvastatin is more effective in reduction of total cholesterol level whereas fenofibrate is more efficient in reduction of triglycerides. The combination had beneficial effects on oxidative stress and on vascular reactivity in hyperlipidemia. [6] [7] [8] Atorvastatin calcium is determined by various methods including high performance liquid chromatography (HPLC), [9] [10] [11] spectrophotometry, 12 HPLC-electron tandem massspectroscopy, 13, 14 and electrochemical methods, 15, 16 in plasma, in pharmaceutical formulations and in bulk. We also determined its impurities, enantiomers, intermediates and metabolites. Fenofibrate is determined by spectrophotometry, 17 square-wave voltammetry, 18 HPLC, and nuclear magnetic resonance (NMR), [19] [20] [21] in pharmaceutical formulations, raw materials, plasma and serum, and impurities, and in bioactive metabolites.
There is no report about the simultaneous estimation of this combination in synthetic mixtures or in pharmaceutical formulations.
In order to resolve complex spectra and to avoid timeconsuming separation, we attempted for simultaneous determinations using ratio derivative techniques 22 and chemometric methods.
The chemometric methods proposed in this paper presume that there is a linear relationship between absorbance and component concentration. These methods have a calibration step followed by the prediction step, in which the results of the calibration step are used to estimate the component concentration from an unknown sample spectrum. The three chemometric methods other than the ILS method have many full spectrum advantages. These methods are known to provide additional advantages that calibration can be performed by ignoring the concentration of all other components except the analyte of interest.
The methods do not require any derivatization, prior separation or sample pretreatment. These methods have been successfully applied to the quantitative analysis in spectrophotometric, [23] [24] [25] [26] [27] [28] [29] chromatographic 30, 31 and electrochemical 32, 33 data. Chemometric calibration techniques are discussed in more detail elsewhere. 1 cm quartz cells over the range of 231 -310 nm. The chemometric calculations on the resulting data were carried out in R-software environment (Ver. 2.1.1; www.r-project.org) which is a GNU implementation of S 46 language and environment which was developed at Bell Laboratories.
Reagents and chemicals
Atorvastatin calcium and fenofibrate were kindly supplied by Biocon India Ltd., India and Dr. Reddy's India, and were certified to be 99.3 and 99.7% pure, respectively. The drugs are used without further purification. All the solvents used in spectrophotometric analysis were of analytical reagent grade. Lorilip tablets batch number I.P. 5022 of Unichem Laboratories Ltd., India, which were claimed to contain 10 mg of ATOR and 200 mg of FENO, are used in analysis.
Standard stock and working solution
ATOR stock solution: 1 mg/ml in methanol. ATOR working solution: a, 0.04 mg/ml in methanol, prepared by transferring 2.0 ml from stock ATOR to a measuring flask 50 ml and completing to volume with methanol; b, 0.002 mg/ml in methanol prepared by transferring 2.5 ml from (a) to a measuring flask 50 ml and completing to volume with methanol. FENO stock solution: 1 mg/ml in methanol. FENO working solution: 0.04 mg/ml in methanol prepared by transferring 2.0 ml from stock FENO to a 50 ml measuring flask and completing to volume with methanol.
Prepared mixtures
In 10 ml measuring flasks, aliquot volumes of ATOR and FENO from their corresponding working solutions were transferred accurately to prepare mixtures containing different ratios of the two drugs, as shown in Table 1 . Furthermore, we demonstrated that in some formulations ATOR levels were extremely low compared to FENO, ranging 1:20. ATOR levels were lower than the detection and quantification limits of this compound. The levels in the prepared mixtures are raised by standard addition of ATOR in its final concentration within the linear calibration range. The amount of standard addition was kept as low as possible to minimize error prediction for the actual ATOR levels. 47 We chose 0.004 mg/ml constant standard addition for ATOR.
UV spectra were recorded in the wavelength range 231 -310 nm versus solvent blank and digitized absorbance was sampled at 1 nm intervals.
Spectral characteristics of ATOR and FENO
Aliquot portions equivalent to 12 μg/ml of ATOR and FENO in methanol were taken separately. Zero-order absorption spectra of both solutions and one binary mixture were recorded (Fig. 1) .
Procedure
Ratio spectra first derivative spectrophotometry. The ratio spectra of different ATOR standards at increasing concentration in methanol were obtained by dividing each with the stored spectrum of the standard solution of 16 μg/ml FENO by computer aid as divisor spectra; these ratio spectra are shown in Fig. 2A . The first derivatives ( 1 DD) of this spectrum traced with interval of Δλ = 8 nm are illustrated in Fig. 2B . As seen in Fig 2B, one minimum (247.5 nm) and one maximum (232.5 nm) exist and we found that both were suitable for determination of ATOR in ATOR and FENO mixtures. The wavelength of 247.5 nm was selected for the determination of this compound in the assay of synthetic mixtures and tablets, due to its lower RSD values and more suitable mean recovery compared with other wavelengths. For the determination of FENO, the ratio spectra of different FENO standards at increasing concentrations in methanol, obtained by dividing each with stored spectrum of the standard solution of 12 μg/ml of ATOR as divisor spectra by computer aid, are demonstrated in Fig. 3A . The first derivatives ( 1 DD) of this spectrum traced with intervals of Δλ = 8 nm are illustrated in Fig. 3B . As seen in Fig. 3B , there exist one minimum (229 nm) and one maximum (254 nm) and in this both were suitable for the determination of FENO in FENO and ATOR mixtures. The peak at wavelength 254 nm was selected because of its lower RSD and more suitable mean recoveries.
Application of the proposed procedure for the simultaneous determination of the two drugs in laboratory prepared mixtures.
The spectra of the prepared mixtures were recorded and stored, then divided by the spectrum of 16 μg/ml of FENO standard solution; then, from derivative spectra the peak amplitude at 1 DD 247.5 nm, the concentration of ATOR in mixtures was obtained by substituting in regression equations. To determine the concentration of FENO in the mixtures, we divided the stored spectra by the spectrum of 12 μg/ml of ATOR standard solution, then from the derivative spectra the peak amplitude at 1 DD 254 nm was obtained and the concentration of FENO in mixtures was calculated by substituting in regression equation. The results obtained are shown in Table 3 . powder equivalent to 10 mg ATOR and 200 mg FENO (content of one tablet) was dissolved in 60 ml of methanol. The solution was stirred for 10 min using a magnetic stirrer and then filtered into a 100 ml volumetric flask through Whatman filter paper No. 40. The residue was washed three times with 10 ml of solvent; then the volume was completed to 100 ml with the same solvent. This solution was diluted to 1:100 with methanol and a 4 μg/ml concentration of ATOR is added as standard addition. Results obtained are shown in Table 7 .
Chemometric methods Classical least squares (CLS).
This method assumes Beer's law model with the absorbance at each frequency being proportional to the component concentrations. In matrix notation, Beer's law model for m calibration standards containing l chemical components with the spectra of n digitized absorbances is given by:
where A is the m × n matrix of calibration spectra, C is the m × l matrix of component concentration, K is the l × n matrix of absorptivity-path length products, and EA is the m × n matrix of spectral errors. K, then represents the matrix of pure component spectra at unit concentration and unit path length. The classical least squares solution to Eq. (1) during calibration is,
where K ∧ indicates least-squares estimates of K. Analysis based on the spectrum a, of unknown components concentration (samples),
where c0 is vector of predicted concentrations and K ∧T is transpose of the matrix K ∧ .
Inverse least squares (ILS).
This method treats that concentration as a function of absorbance. The inverse of Beer's law model for m calibration standards with spectra of n digitized absorbances is given by
where C and A are as before, P is the n × l matrix of unknown calibration coefficient relating the l component concentrations of the spectral intensities, and Ec is the m × l vector of errors. The inverse least square solution during calibration for P in Eq. (2) is
During prediction a, the solution for the analyte concentration in the unknown sample is simply
Since in ILS the number of frequencies cannot exceed the total number of calibration mixtures used, stepwise multiple linear regression has been used for the selection of frequencies. 33 correspond to the covariance square matrix of the A0. Secondly, by using cross-validation in the calibration step, the optimal principal components (or the eigenvectors) corresponding to the large eigenvalues are selected. Using the ordinary linear regression C = a + b × A, we calculate the coefficients a and b: coefficient b = P × Q, where P is the matrix of eigenvectors and Q is C-loadings given by Q = D × T T × A0. Here T T is the transpose of the score matrix T. D is a diagonal matrix having on the diagonal components the inverses of the selected eigenvalues. Knowing b, we found a using formula a = Cmean -A T mean × b, where Cmean represents the mean concentration of the calibration set and A T mean is the transpose of the matrix having the entries of mean absorbance values.
Principal component regression (PCR). The original data obtained in absorbances
The "pcr" function of the R package "pls" (http:// mevik.net/work/software/pls.html) implements the well-known algorithm 37, 48 based on singular value decomposition. This function was used to fit PCR model using the transformed data as input. The "Leave-one-out" (LOO) CROSS validation method was chosen while fitting the PCR model.
Partial least squares (PLS).
The PLS calibration using the orthogonalized PLS algorithm developed by Wold 44 and extensively discussed by Martens and Naes 37 involves simultaneously the independent and the dependent variables on the data compression and decomposition operations resulting in latent variables, A = TP T + E and C = UQ T + F. The vector b is given by b = W(P T W) -1 Q, where W is a PLS weight matrix. By using the linear regression C = a + b × A, the constant a is calculated by a = Cmean -A T mean × b; as in the PCR method, the PLS calibration is used for the estimation of the title drugs.
Similar to the PCR model, the absorbance data A and concentration data C are mean-centered and scaled to obtain the transformed data as A0 and C0, respectively. The "plsr" function of the R package "pls" implements the above-mentioned algorithm. This function is used with the transformed data as input.
Results and Discussion
Ratio derivative methods were used for analysis of mixtures with overlapped spectra.
This method permits the determination of components in mixtures at wavelengths corresponding to a maximum or minimum. The values at these points permit better sensitivity and accuracy. The main instrumental parameters that affect the shape of the derivative ratio spectra are the wavelength scanning speed, the concentration of divisor spectra, smoothing (Δλ) and scaling factor. The effects of these parameters were studied and fast scanning speed, smoothing factor (Δλ = 8), scaling factor (= 10) was selected. Divisor concentration is the main instrumental parameter: the standard spectrum of 12 μg/ml of ATOR and 16 μg/ml of FENO was considered as divisor for the determination of FENO and ATOR in mixtures.
Calibration graphs were established from analytical signals measured at 247.5 nm for standards containing 4 -22 μg/ml of ATOR and at 254 nm for standards containing 2 -20 μg/ml of FENO, from their ratio first derivative spectra, respectively. The analytical parameters are illustrated in Table 2 .
The proposed method was successfully applied for the determination of the two drugs in laboratory-prepared mixtures. Recoveries and relative standard deviations are given in Table 3 and are found satisfactory.
A critical evaluation of this method was performed by statistical analysis of the data, where slopes, intercepts and correlation coefficients are shown in Table 2 . Summary of the assay results for commercial preparation are shown in Table 7 , along with those from the four chemometric methods. The selectivity of the proposed method was also assayed by the analysis of synthetic mixtures, where satisfactory results were obtained over the stated calibration range.
The limit of detection (LOD) and limit of quantitation (LOQ) are calculated according to a formula given by Miller. 49 LOD and LOQ were found to be 0.27 and 0.36 μg/ml for ATOR and 0.90 and 1.21 μg/ml for FENO, respectively.
448
ANALYTICAL SCIENCES APRIL 2007, VOL. 23 Chemometric techniques are other methods gaining wide application for the resolution of the drug mixtures. A calibration set was randomly prepared as mixtures of ATOR and FENO in their possible compositions in methanol in the concentration range illustrated in Table 1 . The UV absorbance data were obtained by measuring the absorbances in the region of 231 -310 nm. By using the correlation between calibration concentration and its absorbance data, the chemometric calibrations were calibrated within the CLS, ILS, PCR and PLS algorithms. The numerical results are shown in Table 4 .
Statistical parameter
The predictive ability of a model in chemometric methods can be defined in various ways. The most general expression is the standard error of calibration (SEC) and prediction (SEP), which is given by the following equation:
Added is the added concentration of drug, C i Found is the predicted concentration of drug and n is the total number of the synthetic mixtures.
Selection of optimum number of factors for PCR and PLS
For PCR and PLS methods, 23 calibration spectra were used for the selection of the optimum number of factors by using the cross validation technique. This allows modelling of the system with the optimum amount of information and avoidance of overfitting or underfitting. The cross-validation procedure consisting of systematically removing one of a group of training samples in turn and using only the remaining ones for the construction of latent factors and applied regression. The predicted concentrations were then compared with the actual
ones for each of the calibration samples and root mean squares error of prediction (MSEP) was calculated. The MSEP was computed in the same manner each time, then, a new factor was added to the PCR and PLS model. The selected model was that with the fewest number of factors such that its MSEP values were not significantly greater than that for the model, which yielded the lowest MSEP. A plot of MSEP values against number of components (Figs. 4 and 5) indicates that factors 5 and 4 were optimum by PCR and PLS, respectively, for the estimation of title drugs. At the selected principal components of PCR and PLS, the concentrations of each sample were then predicted and compared with known concentration and the PRESS (prediction error sum of squares) was calculated. It was given by this equation, and values are indicated in Table 4 .
In order to test the proposed techniques, the validation set of the synthetic mixtures containing the two drugs in variable compositions was analyzed; the results are given in Tables 5  and 6 . The maximum values of the mean percent errors corresponding to CLS, ILS, PCR and PLS for the same mixtures were completely acceptable because of their very small values. The mean recoveries and the relative standard deviations of our proposed methods were computed and indicated in the same table. Their numerical values were found satisfactory for the validity of all calibration methods.
Recovery of the tablet formulation
To check the validity of the proposed methods using standard addition method, we added the standard amount of the pure drugs, as equal to the contents of the tablet formulation, to the tablets. To the final dilutions, 4 μg/ml of ATOR is added as the standard addition described earlier. ILS, PCR and PLS calibrations were found to be 99.7 ± 4.62, 97.84 ± 2.73, 99.52 ± 3.76, 100.74 ± 2.87 and 101.27 ± 3.11. The recovery results were obtained in the average of 5 replicates for each drug.
The numerical values of all statistical parameters indicate that the investigated methods are suitable for the determination of both the drugs in the tablet formulation.
Tablet analysis
Ten tablets were weighed accurately and powdered. An amount of the powder equivalent to 10 mg ATOR and 200 mg FENO (content of one tablet) was dissolved in 60 ml of methanol. The solution was stirred for 10 min using a magnetic stirrer and filtered into a 100 ml volumetric flask through Whatman filter paper No. 40. The residue was washed 3 times with 10 ml of solvent, and then the volume was completed to 100 ml with the same solvent. This solution was diluted to 1:100 with methanol and 4 μg/ml concentration of ATOR was added as standard addition. All the proposed chemometric methods were applied to the solutions. Results obtained are shown in Table 7 .
Conclusions
A simple and precise method involving ratio derivative spectrophotometry and four chemometric techniques was developed for the determination of ATOR and FENO in pharmaceutical formulations. The lower correlation coefficient values 0.947, 0.972, 0.977 and 0.970 for ATOR estimation in CLS, ILS, PCR and PLS were found, respectively. However, this was expected from less differences in concentration quantified in these techniques. Further, after the additions of known amounts of standard drugs to the commercial formulation, we found that the amount of these drugs or their spectra compared to the standard remained unchanged. The proposed methods are less expensive than the application of alternative techniques like chromatography or other methods; hence it can be applied for the routine analysis of these two drugs in the tablet formulation without any pretreatment and without time consumed in quality control laboratories.
